The Evidence Speaks (November 2020)
This edition includes deprescribing algorithms for hemodialysis patients, PROMs in fall prevention, and frailty and health after heart valve surgery
Read MoreAugust 12, 2020
This edition includes deprescribing algorithms for hemodialysis patients, PROMs in fall prevention, and frailty and health after heart valve surgery
Read More
This COVID-19 special edition includes managing chronic kidney disease, facilitating transcatheter aortic valve implantation, and youth mental health and substance use
Read More
This edition includes TB screening in people starting dialysis, early opioid dispensing after a lower back injury, and the burden and risk factors for HBV, HCV, and HIV in Rwanda
Read More
This edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read More
The 31st edition summarizes some of the latest research from CHÉOS Scientists, including epinephrine and out-of-hospital cardiac arrest, kidney disease treatment, and barriers to post-procedure cardiac care.
Read More
The 29th edition summarizes some of the latest research from CHÉOS Scientists, including patient preferences for rheumatoid arthritis prevention, a kidney disease risk-prediction tool, and sleep disturbance in adolescents.
Read More